Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001209191-23-005471

Director acquired 10,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Koenig Scott · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-27 Exercise or conversion : show line 1 in the form +10,500 $2.55 $26,775 15,750 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-27 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −10,500 0 D
Loading xslF345X03/doc4.xml…